00000cam 2200000zi 4500 9.965448 CaOODSP 20260924133125 m o d f cr cn||||||||| 250826s2025 onca os f000 0 eng d CaOODSP eng rda CaOODSP eng fre n-cn--- y0y2 H82-63/2025-PDF Yang, Jihong, author. Navigating the market landscape for rare disease drugs in Canada / Jihong Yang, Tuhin Rahman and Shirin Rizzardo = Comprendre le marché des medicaments pour maladies rares au Canada / Jihong Yang, Tuhin Rahman et Shirin Rizzardo. Comprendre le marché des medicaments pour maladies rares au Canada [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025] 1 online resource (1 page) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier "NPDUIS, National Prescription Drug Utilization Information System." "The emergence of a growing number of expensive drugs for rare diseases (EDRDs) presents new treatment possibilities while raising concerns around affordability and access. This study analyzes EDRDs launched in Canada over the past two decades, using quantitative data to evaluate EDRD trends in drug approvals, drug prices and sales revenues in Canada"--Objective. Text in English and French. Orphan drugs Canada Statistics. Orphan drugs Prices Canada Statistics. Drug approval Canada Statistics. Pharmaceutical industry Canada Statistics. Statistics lcgft Canada. Patented Medicine Prices Review Board, issuing body. Navigating the market landscape for rare disease drugs in Canada / fre (CaOODSP)9.966228 PDF 533 KB https://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-63-2025.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/navigating-market-landscape.html